Jardiance first gained FDA approval in 2014 as a treatment to help lower blood sugar in adults with type 2 diabetes. Now, the drug can also be used to lower the risk of cardiovascular death in ...
Jardiance (empagliflozin) is a brand-name drug that’s prescribed for type 2 diabetes and more. As with other drugs, Jardiance can cause side effects, such as vaginal yeast infections and urinary tract ...
The double-blind EMPEROR-Reduced trial enrolled 3730 adults with HFrEF, with and without diabetes. Boehringer Ingelheim and Lilly announced positive topline results from a phase 3 trial evaluating the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results